The Molecular Imaging and Therapy (MITH) research group is a component of the cutting-edge core facility, ICMI (VUB, Brussel). We are specialized in protein-based radiotheranostics, we excel in every stage — from Nanobody generation, through the design and preclinical validation of fluorescently and/or radio labeled tracers, to the ultimate milestone of clinical validation.
